About

I Don't Just Advise on Respiratory. I've Built Respiratory Businesses.

My work sits at the intersection of respiratory science and commercial reality: which products to build, which devices to back, which manufacturers to trust and how the portfolio earns money in the market.

Why This Consultant

15+ Years Inside the Respiratory Business

Professional experience across established respiratory brands, inhalation devices, respiratory molecules and commercial execution.

"Experience is valuable when it can be converted into better business decisions."

  1. 15+ Years

  2. Respiratory Pharmaceutical Experience

  3. Established Respiratory Brands

  4. Foracort

  5. Seroflo

  6. Inhalation Devices

  7. Respiratory Molecules & Formulations

  8. Commercial Execution

  9. Business Strategy Consulting

Brand names are referenced solely to describe professional experience. No affiliation with, endorsement by, or ownership of any pharmaceutical company or brand is implied.

Philosophy

Respiratory is not a category you enter. It is a business you build.

Commercial before clinical

Every respiratory decision is ultimately a business decision. Structure the economics first.

Focus over breadth

A tight, coherent respiratory basket outperforms a wide, unfocused SKU list.

Execution is strategy

A roadmap only matters if a field team, a manufacturer and a hospital can act on it.

Consultation

Start With a Respiratory Portfolio Audit

A focused diagnostic session for entrepreneurs and pharma business owners who want to evaluate a respiratory opportunity before committing significant capital.

  • Market opportunity review
  • Current portfolio review
  • Investment-range discussion
  • Product strategy
  • Device strategy
  • Manufacturing considerations
  • Institutional potential
  • Priority action plan